Glenmark introduces higher strength of FabiFlu to reduce pill...

Mumbai (Maharashtra) [India], Aug 6 (ANI): Glenmark Pharmaceuticals will introduce a 400 mg version of oral...

Sun Pharma launches Favipiravir in India for Rs 35 per tablet

Mumbai (Maharashtra) [India], Aug 4 (ANI): Sun Pharmaceutical Industries said on Tuesday it has launched...

Converge Biotech announces the launch of Vergiflu...

Hyderabad (Telangana) [India] Aug 4 (ANI/BusinessWire India): Converge Biotech, a leading healthcare company based...

Cipla gets regulatory nod for launch of Ciplenza to treat...

Mumbai (Maharashtra) [India], July 24 (ANI): Pharmaceutical major Cipla said on Friday it has been granted...

COVID-19: DCGI nod to Jubilant Generics to manufacture, sell...

New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma...

DCGI seeks clarification from Glenmark on its anti-viral...

New Delhi [India], July 19 (ANI): The Drugs Controller General of India (DCGI) has asked for a clarification from...

Glenmark cuts COVID-19 drug Favipiravir price by 27 pc

Mumbai (Maharashtra) [India], July 13 (ANI): Glenmark Pharmaceuticals said on Monday it has cut the price of its...

Loyal Textile Mills Limited launched the world's first...

Chennai (Tamil Nadu) [India] July 10 (ANI/NewsVoir): Loyal Textile Mills Limited today launched Viral Shield, a line...

DCGI instructs pharma giants manufacturing remdesivir to...

New Delhi [India], July 9 (ANI): Witnessing the incidence of black marketing and overcharging of the remdesivir...

Mylan gets DCGI nod for remdesivir in India, to launch at Rs...

Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir...

DCGI gives nod to Mylan labs to manufacture remdesivir for...

New Delhi [India], July 2 (ANI): The Drug Controller General of India (DCGI) has granted permission to Mylan...

UK's RECOVERY trial found anti-viral HIV drug "ineffective"on...

New Delhi [India], June 30 (ANI): Researchers from UK's RECOVERY trial (Randomised Evaluation of COVID-19 Therapy)...